Abstract
(DSS). Age-adjusted Charlson Comorbidity Score (HR 1.2, p Z 0.003), LVSI (HR 3.1, p Z 0.003), and RT (HR 0.43, p Z 0.01) were retained in the multivariate model for OS. Conclusions: Adjuvant RT appears to reduce the risk of local-regional failure and improve OS in this cohort of patients with early stage Type II endometrial cancer. However, distant failure is a challenge for women with type II endometrial cancer. Further investigation into optimal adjuvant systemic therapy in these patients appears justified. Author Disclosure: S. Vance: None. N. Rasool: None. M. Mahan: None. M.A. Elshaikh: None.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology*Biology*Physics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
